Resources Contact Us Home
43 Kd protein vaccine and method for the production thereof

Image Number 2 for United States Patent #5543304.

A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

  Recently Added Patents
Meat-containing, strip shaped food product and method of making same
Permanent magnet axial field zeeman slower
Systems and methods for electronic verification of vehicle insurance coverage
OFDM control signaling in the presence of timing asynchronization in a peer-to-peer network
Methods and systems for presenting an inhalation experience
Luggage cart
  Randomly Featured Patents
Signaling system with low-power automatic gain control
Registration of separations
Controlled release of perfluoropolyether antifoam additives from compounded rubber
MOSFET oscillator for supplying a high-power RF inductive load
Motion-picture camera programmed for fadeover effects
Magnetic recording medium
Incrementally updatable system software infrastructure for sensor networks
Method and apparatus for applying additive to fibrous products and products produced thereby
Ventilating device and method for making the same
High density semiconductor integrated circuit layout